BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26437833)

  • 1. High resolution structure of an M23 peptidase with a substrate analogue.
    Grabowska M; Jagielska E; Czapinska H; Bochtler M; Sabala I
    Sci Rep; 2015 Oct; 5():14833. PubMed ID: 26437833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of active LytM.
    Firczuk M; Mucha A; Bochtler M
    J Mol Biol; 2005 Dec; 354(3):578-90. PubMed ID: 16269153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent LytM at 1.3A resolution.
    Odintsov SG; Sabala I; Marcyjaniak M; Bochtler M
    J Mol Biol; 2004 Jan; 335(3):775-85. PubMed ID: 14687573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the Cys74 to Ala74 mutant of the recombinant catalytic domain of Zoocin A.
    Xing M; Simmonds RS; Timkovich R
    Proteins; 2017 Jan; 85(1):177-181. PubMed ID: 27699884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.
    Osipovitch DC; Griswold KE
    FEMS Microbiol Lett; 2015 Jan; 362(2):1-7. PubMed ID: 25670705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans.
    Sabala I; Jagielska E; Bardelang PT; Czapinska H; Dahms SO; Sharpe JA; James R; Than ME; Thomas NR; Bochtler M
    FEBS J; 2014 Sep; 281(18):4112-22. PubMed ID: 25039253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli.
    Sharma R; Sharma PR; Choudhary ML; Pande A; Khatri GS
    Protein Expr Purif; 2006 Jan; 45(1):206-15. PubMed ID: 16181789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Characterization of EnpA D,L-Endopeptidase from
    Małecki PH; Mitkowski P; Jagielska E; Trochimiak K; Mesnage S; Sabała I
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and structural characterization of LytU, a unique peptidoglycan endopeptidase from the lysostaphin family.
    Raulinaitis V; Tossavainen H; Aitio O; Juuti JT; Hiramatsu K; Kontinen V; Permi P
    Sci Rep; 2017 Jul; 7(1):6020. PubMed ID: 28729697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-staphylococcal activities of lysostaphin and LytM catalytic domain.
    Sabala I; Jonsson IM; Tarkowski A; Bochtler M
    BMC Microbiol; 2012 Jun; 12():97. PubMed ID: 22672475
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Raulinaitis V; Tossavainen H; Aitio O; Seppala R; Permi P
    Biomol NMR Assign; 2017 Apr; 11(1):69-73. PubMed ID: 27943001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function analysis of the LytM domain of EnvC, an activator of cell wall remodelling at the Escherichia coli division site.
    Peters NT; Morlot C; Yang DC; Uehara T; Vernet T; Bernhardt TG
    Mol Microbiol; 2013 Aug; 89(4):690-701. PubMed ID: 23796240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LytM Fusion with SH3b-Like Domain Expands Its Activity to Physiological Conditions.
    Jagielska E; Chojnacka O; Sabała I
    Microb Drug Resist; 2016 Sep; 22(6):461-9. PubMed ID: 27351490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the LasA virulence factor from Pseudomonas aeruginosa: substrate specificity and mechanism of M23 metallopeptidases.
    Spencer J; Murphy LM; Conners R; Sessions RB; Gamblin SJ
    J Mol Biol; 2010 Mar; 396(4):908-23. PubMed ID: 20026068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved loop residues-Tyr
    Charoenjotivadhanakul S; Sakdee S; Imtong C; Li HC; Angsuthanasombat C
    Biochem Biophys Res Commun; 2023 Aug; 668():111-117. PubMed ID: 37245291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: Adverse influence of Zn
    Chandra Ojha S; Imtong C; Meetum K; Sakdee S; Katzenmeier G; Angsuthanasombat C
    Protein Expr Purif; 2018 Nov; 151():106-112. PubMed ID: 29944958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K.
    Sanz-Gaitero M; Keary R; Garcia-Doval C; Coffey A; van Raaij MJ
    Virol J; 2014 Jul; 11():133. PubMed ID: 25064136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural bases of peptidoglycan recognition by lysostaphin SH3b domain.
    Mitkowski P; Jagielska E; Nowak E; Bujnicki JM; Stefaniak F; Niedziałek D; Bochtler M; Sabała I
    Sci Rep; 2019 Apr; 9(1):5965. PubMed ID: 30979923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique Substrate Specificity of SplE Serine Protease from Staphylococcus aureus.
    Stach N; Kalinska M; Zdzalik M; Kitel R; Karim A; Serwin K; Rut W; Larsen K; Jabaiah A; Firlej M; Wladyka B; Daugherty P; Stennicke H; Drag M; Potempa J; Dubin G
    Structure; 2018 Apr; 26(4):572-579.e4. PubMed ID: 29526434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octameric structure of Staphylococcus aureus enolase in complex with phosphoenolpyruvate.
    Wu Y; Wang C; Lin S; Wu M; Han L; Tian C; Zhang X; Zang J
    Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2457-70. PubMed ID: 26627653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.